BiotechTube
Home/GenSight Biologics/Dr. Magali Taiel
DM

Dr. Magali Taiel

Chief Medical Officer

GenSight Biologics

Therapeutic Areas

OphthalmologyNeurodegenerative Diseases

GenSight Biologics Pipeline

DrugIndicationPhase
GS010 (lenadogene nolparvovec)Leber Hereditary Optic Neuropathy (LHON) due to ND4 mutationPhase 3
GS030Retinitis Pigmentosa (RP)Phase 1/2
Preclinical ProgramsGeographic Atrophy in Dry Age-Related Macular Degeneration (Dry-AMD)Preclinical

Leadership Team at GenSight Biologics

LR
Laurence Rodriguez
Chief Executive Officer
JE
Jan Eryk Umiastowski
Chief Financial Officer
DS
Dr. Scott Jeffers
Chief Technical Officer
JS
José-Alain Sahel
Scientific Co-Founder
BR
Botond Roska
Scientific Co-Founder
DN
Dr. Nancy J. Newman
Presenter (Emory University) - Key Opinion Leader associated with trial data
View full GenSight Biologics profile